Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib.

× No keyword cloud information.

11 in total

1. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

Authors: Hossein A Ghofrani; Nicholas W Morrell; Marius M Hoeper; Horst Olschewski; Andrew J Peacock; Robyn J Barst; Shelley Shapiro; Heiko Golpon; Mark Toshner; Friedrich Grimminger; Steve Pascoe
Journal: Am J Respir Crit Care Med Date: 2010-06-25 Impact factor: 21.405

Review 2. Alterations in cellular metabolisms after Imatinib therapy: a review.

Authors: Veerandra Kumar; Priyanka Singh; Sonu Kumar Gupta; Villayat Ali; Malkhey Verma
Journal: Med Oncol Date: 2022-05-16 Impact factor: 3.064

3. Genome‑wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor‑resistant CML cells.

Authors: Meike Kaehler; Merit Litterst; Julia Kolarova; Ruwen Böhm; Henrike Bruckmueller; Ole Ammerpohl; Ingolf Cascorbi; Inga Nagel
Journal: Oncol Rep Date: 2022-06-22 Impact factor: 4.136

4. Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis.

Authors: Dhruv Nayyar; Kavitha Muthiah; Gayathri Kumarasinghe; Ravin Hettiarachchi; David Celermajer; Eugene Kotlyar; Anne Keogh
Journal: Pulm Circ Date: 2014-06 Impact factor: 3.017

5. Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.

Authors: Isabelle Deshaies; Jovenel Cherenfant; Niraj J Gusani; Yixing Jiang; Harold A Harvey; Eric T Kimchi; Jussuf T Kaifi; Kevin F Staveley-O'Carroll
Journal: Ther Clin Risk Manag Date: 2010-10-05 Impact factor: 2.423

Imatinib.

1. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

Review 2. Alterations in cellular metabolisms after Imatinib therapy: a review.

3. Genome‑wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor‑resistant CML cells.

4. Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis.

5. Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.

6. Imatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors.

7. Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis.

8. Comparative assessment of strategies to identify similar ligand-binding pockets in proteins.

9. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.

10. Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia.